Therapeutic Area | MeSH |
---|---|
eye diseases | D005128 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
SIMBRINZA | Alcon Research | N-204251 RX | 2013-04-19 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
azopt | New Drug Application | 2023-11-24 |
brinzolamide | ANDA | 2024-07-10 |
simbrinza | New Drug Application | 2025-03-11 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
open-angle glaucoma | EFO_0004190 | D005902 | H40.1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Ocular hypertension | D009798 | EFO_1001069 | H40.0 | 1 | 1 | 1 | — | — | 2 |
Glaucoma | D005901 | EFO_0000516 | H40 | 1 | 1 | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | 1 | 1 | — | — | — | 1 |
Drug common name | Brinzolamide |
INN | brinzolamide |
Description | Brinzolamide is a sulfonamide and a thienothiazine. It has a role as an antiglaucoma drug and an EC 4.2.1.1 (carbonic anhydrase) inhibitor. |
Classification | Small molecule |
Drug class | carbonic anhydrase inhibitors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21 |
PDB | — |
CAS-ID | 138890-62-7 |
RxCUI | — |
ChEMBL ID | CHEMBL220491 |
ChEBI ID | 3176 |
PubChem CID | 68844 |
DrugBank | DB01194 |
UNII ID | 9451Z89515 (ChemIDplus, GSRS) |